| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |